Non-alcoholic fatty liver disease (NAFLD) constitutes a spectrum of disease states
characterized by hepatic steatosis and is closely associated to obesity and the metabolic …

The low grade inflammatory state present in obesity promotes the progression of Non-
Alcoholic Fatty Liver Disease (NAFLD). In Non-Alcoholic Steatohepatitis (NASH) …

Non-alcoholic fatty liver disease (NAFLD) includes a range of hepatic manifestations,
starting with liver steatosis and potentially evolving towards non-alcoholic steatohepatitis …

Non-alcoholic fatty liver disease (NAFLD) is currently the most common liver disease
worldwide, both in adults and children. It is characterized by an aberrant lipid storage in …

Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver
disease worldwide. A significant proportion of patients with NAFLD develop a progressive …

The liver lies at the intersection of multiple metabolic pathways and consequently plays a
central role in lipid metabolism. Pathological disturbances in hepatic lipid metabolism are …

Inflammation and metabolic dysfunction are hallmarks of nonalcoholic steatohepatitis
(NASH), which is one of the fastest‐growing liver diseases worldwide. Emerging evidence …

Nonalcoholic steatohepatitis (NASH) has increased in Western countries due to the
prevalence of obesity. Current interests are aimed at identifying the type and function of …

Non-Alcoholic Steatohepatitis (NASH) is the progressive form of Non-Alcoholic Fatty Liver
Disease (NAFLD), the main cause of chronic liver complications. The development of NASH …

Nonalcoholic fatty liver disease (NAFLD) has become the most common liver disease in the
United States and other developed countries and is expected to increase in the next few …